News and Events
Upcoming Events
Latest Press Releases
March 27, 2026
CIRM approves over $111 million to support discovery and clinical research
March 27, 2026
First therapy funded by California taxpayer dollars is approved to treat rare childhood disorder
January 29, 2026
CIRM approves new $100 million plan to accelerate genetic therapies for patients with rare diseases
CIRM’s Blog: The Stem Cellar
The Stem Cellar
- Progress on Sickle Cell Disease Treatments June 19, 2026Only three years ago, the FDA approved the first gene therapies for sickle cell disease (Lyfgenia and Casvegy), historic breakthroughs decades in the making. Yet on World Sickle Cell Awareness Day this year, the reality is that high cost, limited availability, and complex logistics keep these treatments out of reach for most people who need them. Yet these breakthroughs offer tremendous hope. For many years, the […]
- Understanding the Phases of Clinical Trials: How Success Builds at Every Step June 16, 2026To speed promising new stem cell or gene therapies to patients who need them, the California Institute for Regenerative Medicine (CIRM) supports work at every phase of clinical trials, from early discovery research through clinical testing. CIRM currently supports more than 100 clinical trials in California, conditions that range from rare diseases to cancers and […]
- New Dashboard Helps Californians Find Clinical Trials June 11, 2026More than a decade ago, the California Institute for Regenerative Medicine (CIRM) started funding clinical trials in California. Now, with more than 100 clinical trials directly funded by CIRM and more than double that number running at CIRM-supported facilities throughout the state, the agency is making it easy for anyone to find California cell and gene therapy trials. A new dashboard on the CIRM […]